Quantinno Capital Management LP Has $984,000 Stock Position in Surgery Partners, Inc. $SGRY

Quantinno Capital Management LP lifted its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 435.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 82,520 shares of the company’s stock after purchasing an additional 67,095 shares during the quarter. Quantinno Capital Management LP owned about 0.06% of Surgery Partners worth $984,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in SGRY. Pentwater Capital Management LP increased its position in Surgery Partners by 66.9% in the 3rd quarter. Pentwater Capital Management LP now owns 11,681,000 shares of the company’s stock valued at $252,777,000 after buying an additional 4,681,000 shares in the last quarter. UBS Group AG boosted its holdings in Surgery Partners by 111.4% in the fourth quarter. UBS Group AG now owns 7,803,974 shares of the company’s stock worth $120,571,000 after acquiring an additional 4,113,052 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in Surgery Partners by 528.2% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,959,686 shares of the company’s stock worth $30,277,000 after acquiring an additional 1,647,714 shares in the last quarter. Glenview Capital Management LLC acquired a new stake in Surgery Partners in the second quarter valued at approximately $33,995,000. Finally, Dimensional Fund Advisors LP grew its stake in Surgery Partners by 25.5% in the third quarter. Dimensional Fund Advisors LP now owns 4,860,215 shares of the company’s stock valued at $105,177,000 after acquiring an additional 988,956 shares during the period.

Surgery Partners Price Performance

Shares of NASDAQ:SGRY opened at $15.03 on Monday. The stock has a market cap of $1.97 billion, a price-to-earnings ratio of -21.47, a PEG ratio of 4.08 and a beta of 1.92. The company has a quick ratio of 1.78, a current ratio of 1.95 and a debt-to-equity ratio of 1.18. Surgery Partners, Inc. has a 12-month low of $11.41 and a 12-month high of $24.10. The business’s 50 day moving average is $15.60 and its 200 day moving average is $14.41.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings results on Monday, August 10th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.04. The business had revenue of $848.90 million during the quarter, compared to analyst estimates of $830.03 million. Surgery Partners had a positive return on equity of 0.88% and a negative net margin of 2.63%.Surgery Partners’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.17 EPS. On average, sell-side analysts forecast that Surgery Partners, Inc. will post 0.25 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. Cantor Fitzgerald restated an “overweight” rating and set a $18.00 price objective on shares of Surgery Partners in a report on Tuesday, August 11th. Zacks Research cut Surgery Partners from a “strong-buy” rating to a “hold” rating in a report on Monday, August 10th. Royal Bank Of Canada reduced their price target on shares of Surgery Partners from $20.00 to $19.00 and set an “outperform” rating for the company in a research report on Tuesday, August 11th. Weiss Ratings restated a “sell (e+)” rating on shares of Surgery Partners in a research note on Tuesday, May 26th. Finally, Benchmark restated a “buy” rating on shares of Surgery Partners in a report on Tuesday, August 11th. Seven equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Surgery Partners has an average rating of “Moderate Buy” and a consensus price target of $19.45.

Surgery Partners Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.